Hi folks
Everything about these results scream Buy.
But the only thing wrong about this company is its lack of market penetration and its lack of revenue resulting in cash burn.
Great science, below par management and marketing.
Just my opinion , as always DYOR.
cheer Lies
- Forums
- ASX - By Stock
- LBT
- Ann: Leading Microbiology Journal Publishes APAS Clinical Data
Ann: Leading Microbiology Journal Publishes APAS Clinical Data, page-6
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.73M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.7¢ | $38.37K | 2.191M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1408000 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 1374000 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1408000 | 0.016 |
2 | 512165 | 0.015 |
4 | 1147075 | 0.014 |
4 | 3545520 | 0.013 |
1 | 50000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 1374000 | 8 |
0.020 | 923882 | 5 |
0.021 | 763996 | 2 |
0.022 | 563157 | 2 |
0.024 | 200000 | 1 |
Last trade - 15.06pm 02/10/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |